Skip to content
Screener

Reported August 13, 2026 · Before market open

EPS-$0.02Beat by $1.55
EPS estimate-$1.57

Next report

Nov 17, 2026 (in 3 months)
EPS estimate-$1.46

FAQ

When did Indaptus Therapeutics, Inc. report Q2 2026 earnings?
Indaptus Therapeutics, Inc. (INDP) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Indaptus Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Indaptus Therapeutics, Inc. reported eps of $-0.02 for Q2 2026.
Did Indaptus Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-1.57 by $1.55.
How did Indaptus Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 99.8% from $-9.09.
Where can I find Indaptus Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-037574) and the 10-Q periodic report (0001493152-26-037579) directly on SEC EDGAR. The filing index links above go to sec.gov.